Brief: KeifeRX Announces Research Collaboration & Option Agreement With Amneal Pharmaceuticals
09/01/2026 16:04
Jan 9 (Reuters) - KeifeRX: KEIFERX ANNOUNCES RESEARCH COLLABORATION AND OPTION AGREEMENT WITH AMNEAL PHARMACEUTICALS TO ADVANCE KFRX06, A BRAIN-PENETRANT LRRK2 PROGRAM FOR PARKINSON’S DISEASE KEIFERX: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED Source text: ID:nBw2S77Rwa ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study